fluticasone

(redirected from vilanterol)
Also found in: Medical.
Related to vilanterol: umeclidinium
Translations

fluticasone

n fluticasona
References in periodicals archive ?
Trelegy Ellipta is the triple combination therapy of fluticasone furoate, umeclidinium, and vilanterol in a single Ellipta inhaler.
2]-agonists (LABAs), such as arformoterol, indacaterol, formoterol, olodaterol, salmeterol, and vilanterol
Contract notice: Open house drug discount agreements Vilanterol and fluticasone furoate ATC R03AK10
The closed triple combination therapy consists of three medicines: fluticasone furoate, an inhaled corticosteroid (ICS); umeclidinium, a long-acting muscarinic antagonist (LAMA); and vilanterol, a long-acting beta-adrenergic agonist (LABA).
A Food and Drug Administration advisory panel supported approval of a fluticasone and vilanterol combination to treat asthma in adults--but the majority voted against approval for adolescents, citing a need for more safety and effectiveness data in that younger population.
Two new respiratory combination products were approved in 2013, both for chronic obstructive pulmonary disease: fluticasone/ vilanterol (Breo Ellipta) and umeclidinium/vilanterol (Anoro Ellipta).
This study is designed to evaluate the effect of an experimental inhalation therapy administered once daily via a Novel Dry Powder Inhaler on arterial stiffness compared with placebo and vilanterol over a 24 - week treatment period in subjects with COPD.
2] agonists--the ultra-LABAs--and include indacaterol, carmoterol, vilanterol and olodaterol.
Breo Ellipta contains the corticosteroid fluticasone furoate, as well as vilanterol, a long-acting beta-agonist (LABA).
Relovair combines vilanterol, a novel long-acting beta agonist (LABA), and fluticasone furorate, an inhaled corticosteroid (ICS).
2]-agonist; SAL, salmeterol; SAMA, short-acting muscarinic receptor antagonist; SMI, soft mist inhaler; TIO, tiotropium; UME, umeclidinium; VIL, vilanterol.
It has also been indicated for patients who are on a fixed-dose combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in whom additional treatment of airflow obstruction is desired, or for those who are already receiving umeclidinium and a fixed-dose combination of fluticasone furoate and vilanterol.